Sunshine Biopharma Inc.

About Sunshine Biopharma Inc.

Sunshine Biopharma Inc. is a pharmaceutical company focused on offering and researching life-saving medicines across various therapeutic areas.

Products & Services

Prescription Drugs:Medicines available by prescription for various health conditions.

Essential.9TM:A specific product or brand offered by the company, likely a pharmaceutical or health-related product.

Essential-9TM

Specialties

Oncology Antivirals oncology antivirals

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 6000000 MR: - FA: $6.0 million FAN: 6000000	D: 2026-05-19 FD: 2026-05-19	1 investors
2	RT: Public Offering T: - FT: Public Offering	A: 6000000 MR: - FA: $6.0 Million FAN: 6000000	D: 2026-05-18 FD: 2026-05-18	-
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 2460000 MR: - FA: 2.46 million FAN: 2460000	D: 2025-04-03 FD: 2025-04-03	1 investors
4	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 2460000 MR: - FA: 2.46 million FAN: 2460000	D: 2025-04-02 FD: 2025-04-02	1 investors
5	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 10000000 MR: - FA: approximately $10.0 million FAN: 10000000	D: 2024-02-15 FD: 2024-02-15	1 investors
6	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 10000000 MR: - FA: approximately $10.0 million FAN: 10000000	D: 2024-02-13 FD: 2024-02-13	1 investors
7	RT: Private Placement T: - FT: Private Placement	A: 5000000 MR: - FA: $5.0 Million FAN: 5000000	D: 2023-05-16 FD: 2023-05-16	-
8	RT: Private Placement T: - FT: Private Placement	A: 5000000 MR: - FA: approximately $5 million FAN: 5000000	D: 2023-05-12 FD: 2023-05-12	1 investors

Public Offering Latest

2026-05-19

$6.0M

1 investor (Pro only)

Public Offering 2026-05-18

$6.0M

Registered Direct Offering 2025-04-03

$2.5M

View 7 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Steve Slilaty

CEO & CHAIRMAN

C

Camille Sebaaly

CFO & DIRECTOR

D

David Natan

DIRECTOR

A

Andrew Keller

DIRECTOR

R

Rabi Kiderchah

DIRECTOR

S

Steve Slilaty

CHIEF EXECUTIVE OFFICER

View 5 more team members with Pro

Unlock Full Team Directory

Recent News